A nne Beaufour is a French heiress whose fortune is derived from her family's stake in the French pharmaceutical company, Ipsen. She is the great-granddaughter of the company's founder, Henri Beaufour, who established the laboratory in 1929. The company has grown into a major publicly traded biopharmaceutical group specializing in oncology, neuroscience, and rare diseases.

Anne Beaufour, along with her brother Henri and other family members, controls a majority of the company's shares and voting rights through a holding company. She serves as a member of Ipsen's board of directors, representing her family's long-term interests. While she is not involved in the day-to-day executive management of the company, her position on the board makes her a key figure in the governance of the multi-billion dollar pharmaceutical enterprise. She is known for maintaining a very low public profile.